| Annual Financials | 2024 | 2025 | 2026 | TTM |
Revenue  | 8 | 31 | 32 | 0 |
| Expenses | 5 | 21 | 23 | 0 |
| EBITDA | 4 | 10 | 10 | 0 |
| Operating Profit % | 43 % | 30 % | 30 % | 0 % |
| Depreciation | 1 | 3 | 3 | 0 |
| Interest | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 7 | 7 | 0 |
| Tax | 0 | 2 | 2 | 0 |
| Net Profit | 3 | 5 | 5 | 0 |
| EPS in ₹ | 3.19 | 5.57 | 4.90 | 0.00 |
Invicta Diagnostic
Invicta Diagnostic
59.95
-1.05
(-1.72%)
Market Cap
75.37 Cr
PE Ratio
15.72
Volume
17,600.00
Day High - Low
62.00 - 59.90
52W High-Low
105.00 - 58.10
Key Fundamentals
Market Cap
75.37 Cr
EPS
4.90
PE Ratio
15.72
PB Ratio
1.54
Book Value
39.71
EBITDA
9.76
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
29.63
Debt to Equity
0.12
Actual
Company News
View All News
Invicta Diagnostic's subsidiary Porteus Medical LLP incorporated Porteus Pathogenius LLP as a step-down subsidiary with an initial capital contribution of ₹51,000 for a 51% stake.
Invicta Diagnostic Limited announced that its subsidiary, Porteus Medical LLP, has incorporated Porteus Pathogenius LLP as a step-down subsidiary with a 51% stake.
Invicta Diagnostic launches US tele-radiology
May 23, 2026
May 23, 2026Invicta Diagnostic Limited expanded its tele-radiology services to the United States on May 22, 2026, marking its entry into the international market.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,601.50 | #1 26,833.94 | 52.41 | #1 2,762.90 | 8.15 | #1 510 | -14.98 | 55.74 | |
1,287.20 | 13,244.87 | 76.07 | 814.20 | 16.36 | 182 | 37.25 | 54.17 | |
530.70 | 11,002.88 | 56.37 | 1,645.85 | 22.25 | 185 | 74.66 | 53.04 | |
528.90 | 8,418.25 | 50.82 | 846.00 | 20.48 | 163 | #1 125.46 | 63.61 | |
748.15 | 7,506.99 | 97.23 | 998.85 | 29.74 | 62 | 22.09 | 75.99 | |
534.30 | 1,733.20 | 17.01 | 772.77 | 4.05 | 106 | 101.45 | 37.40 | |
268.05 | 1,396.02 | 44.13 | 310.41 | 21.30 | 34 | -13.89 | 37.61 | |
633.90 | 1,238.84 | #1 16.99 | 498.18 | #1 237.06 | 69 | 65.45 | 71.70 | |
1,245.40 | 1,068.89 | 17.93 | 141.92 | 27.17 | 61 | 22.50 | 52.53 | |
280.90 | 893.56 | -617.56 | 1,319.27 | 12.68 | -3 | -173.86 | 42.07 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
5.37 %
Net Income Growth
14.89 %
Cash Flow Change
53.68 %
ROE
22.79 %
ROCE
85.17 %
EBITDA Margin (Avg.)
-5.41 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 | 2026 |
| Total Assets | 16 | 21 | 60 |
| Fixed Assets | 12 | 10 | 19 |
| Current Assets | 4 | 6 | 34 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 0 | 1 |
| Other Assets | 4 | 12 | 0 |
| Total Equity & Liabilities | 16 | 21 | 60 |
| Current Liabilities | 2 | 2 | 7 |
| Non Current Liabilities | 3 | 3 | 3 |
| Total Equity | 11 | 16 | 50 |
| Reserve & Surplus | 12 | 8 | 37 |
| Share Capital | 0 | 8 | 13 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | 1 | 1 |
| Investing Activities | -10 | -5 |
| Operating Activities | 4 | 7 |
| Financing Activities | 7 | -0 |
Share Holding
| % Holding | Aug 2024 | Nov 2025 | Dec 2025 | Mar 2026 |
| Promoter | 100.00 % | 90.52 % | 66.70 % | 66.70 % |
| FIIs | 0.00 % | 0.00 % | 0.94 % | 4.20 % |
| DIIs | 0.00 % | 0.00 % | 10.22 % | 4.30 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 18.49 % | 18.71 % |
| Others | 0.00 % | 9.48 % | 3.66 % | 6.10 % |
| No of Share Holders | 14 | 34 | 34 | 411 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 17 Apr 2026 |  Extraordinary General Meeting | NA | 17 Apr 2026 | 71.25 | 73.20 |
| 18 May 2026 |  Quarterly Result Announcement | NA | 18 May 2026 | 86.10 | 89.50 |
Technical Indicators
RSI(14)
Neutral 30.98
ATR(14)
Less Volatile 3.77
STOCH(9,6)
Neutral 20.10
STOCH RSI(14)
Oversold 14.39
MACD(12,26)
Bearish -0.86
ADX(14)
Strong Trend 36.59
UO(9)
Bearish 50.40
ROC(12)
Downtrend And Accelerating -10.32
WillR(14)
Oversold -91.69
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
